- Home
- BHST vs INMB Comparison
BHST vs INMB Comparison
Compare BHST & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- INMB
- Stock Information
- Founded
- BHST N/A
- INMB 2015
- Country
- BHST Canada
- INMB United States
- Employees
- BHST N/A
- INMB N/A
- Industry
- BHST
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- BHST
- INMB Health Care
- Exchange
- BHST Nasdaq
- INMB Nasdaq
- Market Cap
- BHST 104.0M
- INMB 109.9M
- IPO Year
- BHST N/A
- INMB 2019
- Fundamental
- Price
- BHST $6.30
- INMB $4.87
- Analyst Decision
- BHST
- INMB Strong Buy
- Analyst Count
- BHST 0
- INMB 2
- Target Price
- BHST N/A
- INMB $21.00
- AVG Volume (30 Days)
- BHST N/A
- INMB 250.5K
- Earning Date
- BHST N/A
- INMB 10-31-2024
- Dividend Yield
- BHST N/A
- INMB N/A
- EPS Growth
- BHST N/A
- INMB N/A
- EPS
- BHST N/A
- INMB N/A
- Revenue
- BHST N/A
- INMB $42,000.00
- Revenue This Year
- BHST N/A
- INMB N/A
- Revenue Next Year
- BHST N/A
- INMB N/A
- P/E Ratio
- BHST N/A
- INMB N/A
- Revenue Growth
- BHST N/A
- INMB N/A
- 52 Week Low
- BHST N/A
- INMB $4.78
- 52 Week High
- BHST N/A
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- INMB 35.68
- Support Level
- BHST N/A
- INMB $6.09
- Resistance Level
- BHST N/A
- INMB $6.26
- Average True Range (ATR)
- BHST 0.00
- INMB 0.36
- MACD
- BHST 0.00
- INMB -0.13
- Stochastic Oscillator
- BHST 0.00
- INMB 3.37
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.